Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.

Tzvetkov NT, Stammler H-G, Georgieva MG, Russo D, Faraone I, Balacheva AA, Hristova S, Atanasov AG, Milella L, Antonov L, Gastreich M (2019)
European journal of medicinal chemistry 179: :404-422.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Tzvetkov, Nikolay T; Stammler, Hans-GeorgUniBi; Georgieva, Maya G; Russo, Daniela; Faraone, Immacolata; Balacheva, Aneliya A; Hristova, Silvia; Atanasov, Atanas G; Milella, Luigi; Antonov, Liudmil; Gastreich, Marcus
Abstract / Bemerkung
A comprehensive study was performed for the first time to compare two structurally related substance classes, namely indazole-5-carboxamides (11-16) and (indazole-5-yl)methanimines (17-22). Both chemical entities are potent, selective and reversible MAO-B inhibitors and, therefore, may serve as promising lead structures for the development of drug candidates against Parkinson's disease (PD) and other neurological disorders. Compounds 15 (Ki = 170 pM, SI = 25907) and 17 (Ki = 270 pM, SI = 16340) were the most potent and selective MAO-B inhibitors in both series. To investigate the multi-target inhibitory activity, all compounds were further screened for their potency against human AChE and BuChE enzymes. Compound 15 was found to be the most potent and selective AChE inhibitor in all series (hAChE IC50 = 78.3 ± 1.7 muM). Moreover, compounds 11 and 17 showed no risk of drug-induced hepatotoxicity and a wider safety window, as determined in preliminary cytotoxicity screening. Molecular modeling studies into the human MAO-B enzyme-binding site supported by a HYDE analysis suggested that the imine linker similarly contributes to the total binding energy in methanimines 17-22 as the amide spacer in their carboxamide analogs 11-16. Amplified photophysical evaluation of compounds 17 and 20, including single X-ray analysis, photochemical experiments, and quantum-chemical calculations, provided insights into their more favourable isomeric forms and structural features, which contribute to their biologically active form and promising drug-like properties. Copyright © 2019 Elsevier Masson SAS. All rights reserved.
Erscheinungsjahr
2019
Zeitschriftentitel
European journal of medicinal chemistry
Band
179
Seite(n)
:404-422
ISSN
0223-5234
eISSN
1768-3254
Page URI
https://pub.uni-bielefeld.de/record/2936493

Zitieren

Tzvetkov NT, Stammler H-G, Georgieva MG, et al. Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European journal of medicinal chemistry. 2019;179::404-422.
Tzvetkov, N. T., Stammler, H. - G., Georgieva, M. G., Russo, D., Faraone, I., Balacheva, A. A., Hristova, S., et al. (2019). Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European journal of medicinal chemistry, 179, :404-422. doi:10.1016/j.ejmech.2019.06.041
Tzvetkov, Nikolay T, Stammler, Hans-Georg, Georgieva, Maya G, Russo, Daniela, Faraone, Immacolata, Balacheva, Aneliya A, Hristova, Silvia, et al. 2019. “Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.”. European journal of medicinal chemistry 179: :404-422.
Tzvetkov, N. T., Stammler, H. - G., Georgieva, M. G., Russo, D., Faraone, I., Balacheva, A. A., Hristova, S., Atanasov, A. G., Milella, L., Antonov, L., et al. (2019). Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European journal of medicinal chemistry 179, :404-422.
Tzvetkov, N.T., et al., 2019. Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European journal of medicinal chemistry, 179, p :404-422.
N.T. Tzvetkov, et al., “Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.”, European journal of medicinal chemistry, vol. 179, 2019, pp. :404-422.
Tzvetkov, N.T., Stammler, H.-G., Georgieva, M.G., Russo, D., Faraone, I., Balacheva, A.A., Hristova, S., Atanasov, A.G., Milella, L., Antonov, L., Gastreich, M.: Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European journal of medicinal chemistry. 179, :404-422 (2019).
Tzvetkov, Nikolay T, Stammler, Hans-Georg, Georgieva, Maya G, Russo, Daniela, Faraone, Immacolata, Balacheva, Aneliya A, Hristova, Silvia, Atanasov, Atanas G, Milella, Luigi, Antonov, Liudmil, and Gastreich, Marcus. “Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.”. European journal of medicinal chemistry 179 (2019): :404-422.

Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 31265934
PubMed | Europe PMC

Suchen in

Google Scholar